MarketPulse

equity investment

7 articles
The Motley FoolThe Motley Fool··Thomas Niel

SpaceX IPO Looms: Three Public Companies Offer Backdoor Entry Before Launch

SpaceX targets early 2026 IPO at potential $2 trillion valuation. Investors can gain indirect exposure through Alphabet, Bank of America, and EchoStar stakes.
BACBACpBBACpEBACpKBACpL+14satellite communicationsequity investment
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Liberty Gold Completes $72.5M Goldstrike Sale, Refocuses on Black Pine Project

Liberty Gold sells Goldstrike Project to Heliostar Metals for $72.5M, redirecting capital toward flagship Black Pine Oxide development in Idaho.
CGAUgold miningequity investment
BenzingaBenzinga··Tanya Rawat

Perfect Moment Stock Plunges Despite $12M Financing as Luxury Brand Struggles

Perfect Moment stock tumbles 11.21% after hours despite announcing $12M financing, with luxury brand down 78.97% annually amid persistent investor concerns.
PMNTstock declineafter-hours trading
BenzingaBenzinga··Caroline Ryan

Apollo to Acquire KKR's Atlantic Aviation in $10B Deal

Apollo Global Management and GIC acquire KKR's Atlantic Aviation in $10B deal, with KKR generating 15x returns while maintaining reinvestment stake through Q3 close.
APOAPOSAPOpAKKRKKRS+2acquisitionM&A
BenzingaBenzinga··Prnewswire

Azul Exits Chapter 11 with $850M Capital Injection, $2.5B Debt Reduction

Azul exits Chapter 11 bankruptcy after nine months with $850M new capital and $2.5B debt reduction, achieving record-low leverage levels.
UALAALAZULQdebt reductionChapter 11 emergence
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Psyence BioMed Executes Put Option, Issues $5M in Shares to PsyLabs

Psyence BioMed issues $5M in shares to PsyLabs via put option exercise, giving PsyLabs ~50% ownership and strengthening supply chain for psychedelic pharmaceuticals.
PBMPBMWWsupply chainshareholder dilution
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Psyence BioMed Secures Psychedelic Supply via Put Option Deal with PsyLabs

Psyence BioMed secures pharmaceutical-grade psychedelic supply through put option deal with PsyLabs, ensuring reliable access while maintaining liquidity for clinical development.
PBMPBMWWsupply chainpsilocybin